INVO Fertility, Inc. Common Stock (IVF) Stock Price

IVFStock

$1.00−97.38%52W

Market Cap$2.51M

P/E—

PEG Ratio—

Div yield—

Beta2.44

IVF Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-91.93%

Price vs S&P 500 (4W)1.02%

VGM Score51.60

Book Value / Share (Quarterly)$9.16

P/TBV (Annual)0.30x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)102.82%

Cash Flow / Share (Quarterly)$-3.30

Price vs S&P 500 (YTD)-86.30%

Gross Margin (TTM)36.90%

Net Profit Margin (TTM)-158.73%

EPS (TTM)$-560.19

10-Day Avg Trading Volume13.17M

EPS Excl Extra (TTM)$-560.19

Revenue Growth (5Y)45.75%

EPS (Annual)$-199.21

ROI (Annual)-252.32%

Gross Margin (Annual)36.96%

Net Profit Margin (5Y Avg)-447.32%

Cash / Share (Quarterly)$2.99

Revenue Growth QoQ (YoY)23.09%

ROA (Last FY)-115.35%

Revenue Growth TTM (YoY)9.50%

EBITD / Share (TTM)$-15.75

ROE (5Y Avg)-301.08%

Operating Margin (TTM)-122.38%

Cash Flow / Share (Annual)$-14.79

P/B Ratio0.15x

P/B Ratio (Quarterly)0.29x

Net Income / Employee (Annual)$-833,000

EV / Revenue (TTM)-0.10x

Net Interest Coverage (TTM)-6.41x

ROA (TTM)-55.20%

EPS Incl Extra (Annual)$-199.21

Current Ratio (Annual)0.27x

Quick Ratio (Quarterly)0.81x

3-Month Avg Trading Volume3.13M

52-Week Price Return-97.38%

Revenue / Employee (TTM)$257,800

Tangible BV / Share (Quarterly)$8.32

P/S Ratio (Annual)0.33x

Asset Turnover (Annual)0.34x

52-Week High$84.40

Operating Margin (5Y Avg)-374.89%

EPS Excl Extra (Annual)$-199.21

CapEx CAGR (5Y)-13.57%

26-Week Price Return-80.00%

Quick Ratio (Annual)0.22x

13-Week Price Return-41.18%

Total Debt / Equity (Annual)0.28x

Current Ratio (Quarterly)0.90x

Enterprise Value$-722,900

Revenue / Share Growth (5Y)72.26%

Asset Turnover (TTM)0.35x

Revenue / Employee (Annual)$244,300

Inventory Turnover (Annual)19.38x

Pretax Margin (Annual)-80.20%

Cash / Share (Annual)$4.35

3-Month Return Std Dev250.84%

Gross Margin (5Y Avg)54.66%

Net Income / Employee (TTM)$-409,200

ROE (Last FY)-322.85%

Net Interest Coverage (Annual)-20.40x

EPS Basic Excl Extra (Annual)$-199.21

P/FCF (TTM)170.31x

Receivables Turnover (TTM)34.21x

Total Debt / Equity (Quarterly)0.13x

EPS Incl Extra (TTM)$-560.19

Receivables Turnover (Annual)41.42x

ROI (TTM)-110.60%

P/S Ratio (TTM)0.32x

Pretax Margin (5Y Avg)-389.91%

Revenue / Share (Annual)$58.43

Tangible BV / Share (Annual)$12.36

Price vs S&P 500 (52W)-115.93%

Year-to-Date Return-73.47%

5-Day Price Return-2.91%

EPS Normalized (Annual)$-199.21

ROA (5Y Avg)-101.60%

Net Profit Margin (Annual)-340.92%

Month-to-Date Return6.75%

EBITD / Share (Annual)$-66.33

Operating Margin (Annual)-123.42%

LT Debt / Equity (Annual)0.10x

ROI (5Y Avg)-145.38%

LT Debt / Equity (Quarterly)0.04x

EPS Basic Excl Extra (TTM)$-560.19

P/TBV (Quarterly)0.32x

P/B Ratio (Annual)0.25x

Inventory Turnover (TTM)20.66x

Pretax Margin (TTM)-132.05%

Book Value / Share (Annual)$15.13

Price vs S&P 500 (13W)-43.13%

Beta2.44x

P/FCF (Annual)1.81x

Revenue / Share (TTM)$4.41

ROE (TTM)-149.16%

52-Week Low$0.90

vGradeB

gGradeB

mGradeF

vgmGradeC

IVF Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2026	Jun 22, 2026	-$10.00	-$3.36	+66.37%(+$6.64)

IVF Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
IVFINVO Fertility, Inc. Common Stock	B	B	F	$1.00
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About INVO Fertility, Inc. Common Stock

INVO Fertility Inc. is a healthcare company focused on expanding access to assisted reproductive technology through its proprietary INVOcell medical device, which enables fertilization and early embryo development to occur within the patient's body. The company operates through three revenue-generating segments: clinical services (including its WFI and Atlanta-based clinics), INVOcell device manufacturing and sales, and therapeutics through its acquired subsidiary NTI. This diversified model combines direct patient care with medical device commercialization to address the growing fertility treatment market.